๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Epstein-Barr Virus Infections

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL NCT06559189Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: CD19x22 CAR T Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085Phase 3231 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage Children's Oncology Group ยท Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. NCT07670468Phase 1, Phase 21 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening NCT05447169n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: EBV antibodies test, EBV DNA test TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. NCT04013802Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: HLA-matched VSTs EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Baltimore New York Medical College ยท Tests: cytotoxic t-lymphocytes A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) NCT07570173Phase 2, Phase 328 sites๐Ÿ“ Toronto๐Ÿ“ Copenhagen๐Ÿ“ Aarhus Nord Merck Sharp & Dohme LLC ยท Tests: MK-1045, Blinatumomab, Acetaminophen, Diphenhydramine, Dexamethasone International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) NCT07476729Phase 321 sites๐Ÿ“ Vienna๐Ÿ“ Ghent๐Ÿ“ Prague Charite University, Berlin, Germany ยท Tests: Inotuzumab ozogamicin (INO), Blinatumomab Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab NCT06287229Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Blinatumomab, Inotuzumab Ozogamicin, Hyper-CVAD, Mini-hyper-CVD Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia NCT06793241EARLY Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells injection A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) NCT05667506Phase 1, Phase 29 sites๐Ÿ“ Hefei๐Ÿ“ Chongqing๐Ÿ“ Guangzhou Juventas Cell Therapy Ltd. ยท Tests: single dose of CNCT19 Epstein-Barr Virus and Cancer Risks NCT06203314n/a2 sites๐Ÿ“ Zhongshan๐Ÿ“ Wuzhou Sun Yat-sen University ยท Tests: Diagnostic test: EBV antibody tests Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites๐Ÿ“ Bundang Gu๐Ÿ“ Seongnam-si๐Ÿ“ Gyeonggi-do Novartis Pharmaceuticals ยท Tests: Tisagenlecleucel A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) NCT06173518Phase 114 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ Aurora Autolus Limited ยท Tests: AUTO1 Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma NCT07532525Phase 11 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Biospecimen Collection, Pomalidomide Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL NCT04260022Phase 19 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Atlanta Ascentage Pharma Group Inc. ยท Tests: Ascentage Pharma HQP1351 bioavailable inhibitor, Blinatumomab UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL NCT04544592Phase 1, Phase 21 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRฮฑฮฒ/CD19 Depleted HSCT NCT03810196NA1 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: CliniMACS Cell Processing System for TCRฮฑฮฒ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia NCT03136146Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone, Etoposide Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies NCT07523555Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous CD19/CD22 dual-target CAR-T module, Autologous CD19/CD20 dual-target CAR-T module, Autologous BCMA/CD19 dualโ€ฆ "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site๐Ÿ“ Zhuhai Ming-Yuan Chen ยท Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participantsโ€ฆ Golidocitinib Combined With Selinexor for CAEBVD NCT07369739Phase 2, Phase 31 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: golidocitinib, Selinexor (combination therapy) EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders NCT07450391Phase 1, Phase 21 site๐Ÿ“ Beijing Daihong Liu ยท Tests: EBV-AST Cell Injection Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas NCT03258567Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Nivolumab Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma NCT04491370Phase 1, Phase 21 site๐Ÿ“ Valhalla New York Medical College ยท Tests: Polatuzumab vedotin Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies NCT07239323Phase 11 site๐Ÿ“ Kunming Chongqing Precision Biotech Co., Ltd ยท Tests: Invivo CAR-T Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL NCT06507514Phase 11 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: blinatumomab and auto-HSCT "sandwich " strategy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy